Therapeutic Radiopharmaceuticals
- Name
- Therapeutic Radiopharmaceuticals
- Accession Number
- DBCAT002562
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Ibritumomab tiuxetan A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. Tositumomab A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. Samarium (153Sm) lexidronam A chelated complex of samarium isotope and EDTMP that concentrates in areas with high bone turnover such as sites of metastases to relieve pain associated with osteoblastic metastatic bone lesions. Iobenguane A radiopharmaceutical agent used for the diagnosis of primary and metastatic pheochromocytoma or neuroblastoma. Strontium chloride Sr-89 A radiopharmaceutical agent used for the relief of bone pain in patients with painful skeletal metastases. Yttrium Y-90 Yttrium 90 has been investigated for the treatment of Colon Cancer and Colorectal Cancer. Gold Au-198 Not Annotated Rhenium Re-186 sulfide Not Annotated Iodide I-131 A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine. Sodium phosphate P 32 Not Annotated Lutetium Lu-177 vipivotide tetraxetan A radioligand therapeutic agent used to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer in adults. Omburtamab I-131 Not Annotated - Drugs & Drug Targets